hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.

BACKGROUND: Hypoxia is an important mechanism of treatment resistance in head and neck squamous cell carcinoma (HNSCC). MicroRNAs are short noncoding RNAs that regulate multiple mRNAs and are frequently dysregulated in cancer. The authors have investigated the role of 3 microRNAs, including the hyp...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Gee, H, Camps, C, Buffa, F, Patiar, S, Winter, S, Betts, G, Homer, J, Corbridge, R, Cox, G, West, C, Ragoussis, J, Harris, A
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
de réir: Camps, C, et al.
Foilsithe / Cruthaithe: (2008)

The role of hypoxia-inducible MIR-210 in the biology and prognosis of clear cell kidney cancer
de réir: McCormick, I, et al.
Foilsithe / Cruthaithe: (2011)

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
de réir: Winter, S, et al.
Foilsithe / Cruthaithe: (2007)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.
de réir: Betts, G, et al.
Foilsithe / Cruthaithe: (2013)

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
de réir: Betts, G, et al.
Foilsithe / Cruthaithe: (2013)

"Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.
de réir: Thomas Bertero, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
de réir: Irlam-Jones, J, et al.
Foilsithe / Cruthaithe: (2016)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis
de réir: Moller-Levet, C, et al.
Foilsithe / Cruthaithe: (2009)

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
de réir: McCormick, R, et al.
Foilsithe / Cruthaithe: (2013)

MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
de réir: McCormick, R, et al.
Foilsithe / Cruthaithe: (2013)

Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer
de réir: Mutian Lian, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Research Advance of Hypoxia-regulated miR-210 in Cancer
de réir: CAO Zheng, et al.
Foilsithe / Cruthaithe: (2018-07-01)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
de réir: Gee, H, et al.
Foilsithe / Cruthaithe: (2011)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.
de réir: Gee, H, et al.
Foilsithe / Cruthaithe: (2011)

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.
de réir: Thurlow, J, et al.
Foilsithe / Cruthaithe: (2010)

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU
de réir: Favaro, E, et al.
Foilsithe / Cruthaithe: (2010)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
de réir: Jia Ji, et al.
Foilsithe / Cruthaithe: (2018-12-01)

ROD1 is a seedless target gene of hypoxia-induced miR-210.
de réir: Pasquale Fasanaro, et al.
Foilsithe / Cruthaithe: (2012-01-01)

The role of hypoxia regulated microRNAs in cancer.
de réir: McCormick, R, et al.
Foilsithe / Cruthaithe: (2010)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
de réir: Eustace, A, et al.
Foilsithe / Cruthaithe: (2013)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
de réir: Camile B. Lopes, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
de réir: Carla S Moller-Levet, et al.
Foilsithe / Cruthaithe: (2009-11-01)

Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer.
de réir: Ailin Qu, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Hypoxia-induced miR-210 modulates the inflammatory response and fibrosis upon acute ischemia
de réir: Zaccagnini Germana, et al.
Foilsithe / Cruthaithe: (2021-05-01)

Gene expression signatures as biomarkers of tumour hypoxia
de réir: Harris, B, et al.
Foilsithe / Cruthaithe: (2015)

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.
de réir: Elena Favaro, et al.
Foilsithe / Cruthaithe: (2010-04-01)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
de réir: Ramachandran, A, et al.
Foilsithe / Cruthaithe: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
de réir: Ramachandran, A, et al.
Foilsithe / Cruthaithe: (2013)

Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study
de réir: Rachel E Powell, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Retraction: Hypoxia-Inducible MiR-210 Is an Independent Prognostic Factor and Contributes to Metastasis in Colorectal Cancer.
de réir: PLOS ONE Editors
Foilsithe / Cruthaithe: (2020-01-01)

Hypoxia-preconditioned WJ-MSC spheroid-derived exosomes delivering miR-210 for renal cell restoration in hypoxia-reoxygenation injury
de réir: Reyhaneh Toghiani, et al.
Foilsithe / Cruthaithe: (2024-07-01)

MicroRNA-10b and breast cancer metastasis.
de réir: Gee, H, et al.
Foilsithe / Cruthaithe: (2008)

Ebola virus infection, human Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p and predicted targets
de réir: Beuy Joob, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) in relation to age, gender and histopathological parameters.
de réir: Shaimaa H Mudhir, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
de réir: Noemi Cerón-Pisa, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Paracrine effects of mir-210-3p on angiogenesis in hypoxia-treated c-kit-positive cardiac cells
de réir: Louyi Shen, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis
de réir: Hao Cheng, et al.
Foilsithe / Cruthaithe: (2020-06-01)

miR-210 Protects Renal Cell Against Hypoxia-induced Apoptosis by Targeting HIF-1 Alpha
de réir: Li-Li Liu, et al.
Foilsithe / Cruthaithe: (2017-10-01)

The validity of salivary microRNAs (hsa-miR-200a, hsa-miR-125a and hsa- miR-93) as oral squamous cell carcinoma biomarker
de réir: Shaimaa H Mudhir, et al.
Foilsithe / Cruthaithe: (2014-09-01)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
de réir: Buffa, F, et al.
Foilsithe / Cruthaithe: (2010)